Exprimental Study on the Protective Action of rhGM-CSF for Acute Lung Injury
DOI:
https://doi.org/10.37591/rrjomst.v8i3.1686Abstract
Anti-cancer agents and radiation therapies result in various complications on respiratory systems like interstitial pneumonia, acute lung damage, bacterial pneumonia and pneumomycosis in clinical oncology. Recently it is being interested in variable rolls of GM-CSF to protect the lungs. We infuse the ethyl alcohol and lipopolysaccharide (LPS) to damage lung orally, and then inject GM-CSF subcutaneously at the same time and then observe the changes of lung tissue. As a result, the number of total leucocytes, neutrophil, macrophage, total protein content, MPO, MDA, the number of alveoli per unit square meter, parenchyma thickness in the case with a dosage of 5μg/kg and 10μg/kg are decreased significantly than normal and control group. Settings and Design: We have infused 40% ethyl alcohol and LPS with a dose of 1.0mL/100g for 7 days orally to make a model of acute lung injury. And then we have injected with an rhGM-CSF dosage of 5μg/kg subcutaneously before infusion of alcohol and LPS so as to define the protective effectiveness from acute lung injury of GM-CSF. Results: The number of total leucocytes, neutrophil, macrophage, total protein content, MPO, MDA, the number of alveoli per unit square meter, parenchyma thickness in the case with a dosage of 5μg/kg and 10μg/kg are decreased significantly than normal and control group. Conclusions: We found out the protective action of acute lung injury of GM-CSF. Rational dosage of GM-CSF is 5μg/kg, and the number of total leucocytes, neutrophil and macrophage in the case with a dosage of 5μg/kg and 10μg/kg are increased significantly rather than the control group.
Keywords: GM-CSF, lipopolysaccharide (LPS), protective action, pneumomycosis, lipopolysaccharide, parenchyma
Cite this Article
Hyon-Min Ryang, Hye-Yong Nam. Experimental Study on the Protective Action of rhGM-CSF for Acute Lung Injury. Research & Reviews: Journal of Medical Science and Technology. 2019; 8(3): 4–8p.
Downloads
Additional Files
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |